m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD

m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD

Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer worldwide. However, the survival rate of LUAD patients remains low. N6-methyladenosine (m6A) and long noncoding RNAs (lncRNAs) play vital roles in the prognostic value and the immunotherapeutic response of LUAD. Thus, discerning...

Full description

Bibliographic Details
Main Authors: Feng Xu, Xiaoling Huang, Yangyi Li, Yongsong Chen, Ling Lin
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
N6-methyladenosine
m6A
long noncoding RNAs
lncRNAs
prognosis
lung adenocarcinoma
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253121000974

Internet

http://www.sciencedirect.com/science/article/pii/S2162253121000974

Similar Items